
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Clover Health Investments Corp (CLOV)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/11/2025: CLOV (5-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 116.8% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.72B USD | Price to earnings Ratio - | 1Y Target Price 4.75 |
Price to earnings Ratio - | 1Y Target Price 4.75 | ||
Volume (30-day avg) 5938407 | Beta 2.01 | 52 Weeks Range 0.61 - 4.87 | Updated Date 03/11/2025 |
52 Weeks Range 0.61 - 4.87 | Updated Date 03/11/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.09 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-03-10 | When Before Market | Estimate -0.065 | Actual -0.05 |
Profitability
Profit Margin -3.14% | Operating Margin (TTM) -6.37% |
Management Effectiveness
Return on Assets (TTM) -4.99% | Return on Equity (TTM) -14.75% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1389815072 | Price to Sales(TTM) 1.25 |
Enterprise Value 1389815072 | Price to Sales(TTM) 1.25 | ||
Enterprise Value to Revenue 1.01 | Enterprise Value to EBITDA -0.65 | Shares Outstanding 418532000 | Shares Floating 400750113 |
Shares Outstanding 418532000 | Shares Floating 400750113 | ||
Percent Insiders 5.09 | Percent Institutions 22.38 |
Upturn AI SWOT
Clover Health Investments Corp. (CLOV) - A Comprehensive Overview
Disclaimer: This information is intended for informational purposes only and should not be considered investment advice. Please consult a professional financial advisor before making any investment decisions.
Company Profile:
History and Background: Clover Health is a relatively young company, founded in 2013. The company initially focused on providing Medicare Advantage plans to seniors in the United States. However, in 2021, Clover Health went public through a Special Purpose Acquisition Company (SPAC) merger with Social Capital Hedosophia Holdings Corp. The company's stock is currently traded on the Nasdaq exchange under the ticker symbol CLOV.
Core Business Areas: Clover Health operates in two primary business areas:
- Medicare Advantage Plans: Clover Health offers a variety of Medicare Advantage plans to seniors in the United States. These plans provide comprehensive healthcare coverage, including hospitalization, doctor visits, and prescription drugs.
- Clover Assistant: Clover Assistant is a software platform that uses artificial intelligence (AI) to help manage the healthcare needs of Clover Health's members. Clover Assistant can help members schedule appointments, track their health information, and receive personalized recommendations.
Leadership Team and Corporate Structure: Clover Health's leadership team consists of experienced individuals with a strong track record in the healthcare industry. The company's CEO is Vivek Garipalli, who previously founded and sold a healthcare technology company.
Top Products and Market Share:
Top Products:
- Clover Assistant - AI-powered health management platform
- Clover Health Medicare Advantage plans
Market Share:
- Clover Health currently holds a small market share in the Medicare Advantage market. However, the company is growing rapidly and expects to increase its market share in the coming years.
Comparison with Competitors: Clover Health's primary competitors include:
- Humana (HUM)
- Centene (CNC)
- UnitedHealth Group (UNH)
Clover Health differentiates itself from its competitors by offering a more personalized and technology-driven approach to healthcare.
Total Addressable Market: The total addressable market for Medicare Advantage plans in the United States is approximately 28 million people. This market is expected to grow significantly in the coming years as the population ages.
Financial Performance:
Recent Financial Statements: Clover Health is a relatively young company and has yet to achieve profitability. However, the company is growing rapidly and is expected to reach profitability in the near future.
Year-over-Year Comparison: Clover Health's revenue has grown significantly in recent years. However, the company is still reporting net losses.
Cash Flow and Balance Sheet: Clover Health's cash flow and balance sheet are relatively healthy. The company has a strong cash position and low levels of debt.
Dividends and Shareholder Returns: Clover Health does not currently pay dividends. The company's shareholder returns have been mixed since its IPO.
Growth Trajectory:
Historical Growth: Clover Health has experienced significant revenue growth in recent years. The company's membership base has also grown rapidly.
Future Growth: Clover Health is expected to continue to grow rapidly in the coming years. The company is expanding its Medicare Advantage plan offerings and investing heavily in its Clover Assistant platform.
Growth Initiatives:
- Expansion of Medicare Advantage plan offerings
- Investment in Clover Assistant platform
- Partnerships with other healthcare providers
Market Dynamics:
Industry Overview: The Medicare Advantage market is growing rapidly as the population ages. The market is also becoming increasingly competitive as more healthcare providers enter the space.
Clover Health's Position: Clover Health is well-positioned to benefit from the growth of the Medicare Advantage market. The company's technology-driven approach to healthcare is attractive to seniors, and Clover Health is expanding its plan offerings to meet the needs of a diverse population.
Competitors:
Key Competitors:
- Humana (HUM)
- Centene (CNC)
- UnitedHealth Group (UNH)
Competitive Advantages:
- Technology-driven approach to healthcare
- Personalized member experience
- Rapid growth
Competitive Disadvantages:
- Small market share
- Lack of profitability
- High competition
Potential Challenges and Opportunities:
Challenges:
- Competition from larger healthcare providers
- Maintaining profitability
- Managing regulatory changes
Opportunities:
- Growth of the Medicare Advantage market
- Expansion into new markets
- Partnerships with other healthcare providers
Recent Acquisitions (last 3 years):
Clover Health has not made any significant acquisitions in the past 3 years.
AI-Based Fundamental Rating:
Rating: 5/10
Justification: Clover Health is a growing company with a promising future. However, the company is still relatively young and has yet to achieve profitability. The company also faces significant competition from larger healthcare providers.
Sources:
- Clover Health Investor Relations website
- Yahoo Finance
- Seeking Alpha
Further Research & Disclaimer: This overview is not exhaustive and should not be considered investment advice. Please conduct your own research and consult with a financial professional before making any investment decisions.
About Clover Health Investments Corp
Exchange NASDAQ | Headquaters Franklin, TN, United States | ||
IPO Launch date 2001-01-02 | Co-Founder, CEO & Director Mr. Andrew Toy | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 570 | Website https://www.cloverhealth.com/en/ |
Full time employees 570 | Website https://www.cloverhealth.com/en/ |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.